Udveje Behandling Aps: Financial statements 2022
CVR: 40518916
Source: annual report 2022, Danish Business Authority
01/10/2021 – 30/09/2022
Udveje Behandling Aps (CVR 40518916) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,964,105 and a net result of DKK 236,798 compared with DKK 222,294 the year before. That is an increase of 84.1% compared with the year before. Equity in the 2022 report amounted to DKK 444,513. The solvency ratio was 40.6%.
- Gross Profit
- DKK 1,964,105
- Profit/Loss
- DKK 236,798
- Equity
- DKK 444,513
- Total Assets
- DKK 1,094,578
Official annual report
Keep an eye on Udveje Behandling Aps
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
Udveje Behandling Aps has published its annual report for 2021. Gross profit came to DKK 1,066,649, and the net result was DKK 222,294.
As of January 29, 2022, Rolf Nolsøe Bau has joined the board of directors of Udveje Behandling Aps.
As of January 29, 2022, Claus Christiansen has joined the board of directors of Udveje Behandling Aps.
As of January 29, 2022, Tanja Schlein Andersen has joined the board of directors of Udveje Behandling Aps.
As of January 29, 2022, Kenn Vagn Thomsen has joined the board of directors of Udveje Behandling Aps.
As of January 29, 2022, Ole Vedel Rasmussen has joined the board of directors of Udveje Behandling Aps.
About Udveje Behandling Aps
Udveje Behandling Aps is a Danish company of the type Anpartsselskab based in Store Merløse, founded in 2019. The company is registered under the industry Traditionelle, komplementære og alternative behandlingsformer. The company was previously named Udveje ApS. The management consists of John Kastrup. The board consists of Rolf Nolsøe Bau (chair), Chit Calopez Lodberg, Claus Christiansen and Kirsten Benediktson. The company is owned by UDVEJE Holding ApS. The company has 17 employees (2026). In 2025, the company reported a gross profit of DKK 4,937,535 and a net result of DKK 64,996 compared with DKK 541,297 the year before. Equity in the 2025 report amounted to DKK 675,868.